Finance

Lists
2575:HKG
Xuanzhu Biopharmaceutical Co Ltd
8,28 HKD
-1,84%
(-0,15) 1D
13 ოქტ, 16:08:26 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2575...
Open
8,22 HKD
High
8,70 HKD
Low
8,06 HKD
Mkt. cap
4,29 მლრდ.
Avg. vol.
3,07 მლნ.
Volume
6,15 მლნ.
52-wk high
96,90 HKD
52-wk low
8,00 HKD
EPS
-0,56 HKD
Shares outstanding
160,70 მლნ.
No. of employees
344
Open
8,22 HKD
High
8,70 HKD
Low
8,06 HKD
Mkt. cap
4,29 მლრდ.
Avg. vol.
3,07 მლნ.
Volume
6,15 მლნ.
52-wk high
96,90 HKD
52-wk low
8,00 HKD
EPS
-0,56 HKD
Shares outstanding
160,70 მლნ.
No. of employees
344
News stories
From web sources and news partners
About Xuanzhu Biopharmaceutical Co Ltd
CEO-
Employees344
Founded2008
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
16,94 მლნ.
16,94 მლნ.
34,72 მლნ.
34,72 მლნ.
Cost of goods sold
6,67 მლნ.
6,67 მლნ.
27,05 მლნ.
27,05 მლნ.
Cost of revenue
6,67 მლნ.
6,67 მლნ.
27,05 მლნ.
27,05 მლნ.
Research and development expenses
20,24 მლნ.
20,24 მლნ.
13,75 მლნ.
13,75 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
46,06 მლნ.
46,06 მლნ.
32,94 მლნ.
32,94 მლნ.
Operating expense
69,54 მლნ.
69,54 მლნ.
47,10 მლნ.
47,10 მლნ.
Total operating expenses
76,21 მლნ.
76,21 მლნ.
74,16 მლნ.
74,16 მლნ.
Operating income
-59,27 მლნ.
-59,27 მლნ.
-39,44 მლნ.
-39,44 მლნ.
Other non operating income
-7,68 მლნ.
-7,68 მლნ.
1,78 მლნ.
1,78 მლნ.
EBT including unusual items
-67,30 მლნ.
-67,30 მლნ.
-37,67 მლნ.
-37,67 მლნ.
EBT excluding unusual items
-68,95 მლნ.
-68,95 მლნ.
-37,67 მლნ.
-37,67 მლნ.
Income tax expense
-
-
3,00 ათ.
3,00 ათ.
Effective tax rate
-
-
-0,01%
-0,01%
Other operating expenses
3,24 მლნ.
3,24 მლნ.
413,50 ათ.
413,50 ათ.
Net income
-67,30 მლნ.
-67,30 მლნ.
-37,67 მლნ.
-37,67 მლნ.
Net profit margin
-397,30%
-397,30%
-108,49%
-108,49%
Earnings per share
-
-
-
-
Interest and investment income
1,65 მლნ.
1,65 მლნ.
-
-
Interest expense
-47,50 ათ.
-47,50 ათ.
-5,50 ათ.
-5,50 ათ.
Net interest expenses
1,60 მლნ.
1,60 მლნ.
-5,50 ათ.
-5,50 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-51,68 მლნ.
-51,68 მლნ.
-32,61 მლნ.
-32,61 მლნ.
Gain or loss from assets sale
-894,00 ათ.
-894,00 ათ.
-2,54 მლნ.
-2,54 მლნ.
AI content may include mistakes. Learn more
Google აპები